MEDIROM Healthcare Technologies Inc., together with its subsidiaries, provides holistic health services in Japan. It operates through three segments: Relaxation Salon; Digital Preventative Healthcare; and Luxury Beauty. The Relaxation Salon segment develops, owns, operates, franchises, and supports relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology. This segment operates relaxation salons under the Re.Ra.Ku and Ruam Ruam brands. The Digital Preventative Healthcare segment offers government-sponsored Specific Health Guidance program that utilizes Lav, an on-demand health monitoring smartphone application, as well as MOTHER Bracelet for fitness and health applications; and provides preventative healthcare services utilizing nutritionists and health nurses. The Luxury Beauty segment manages and operates hair salons under the ZACC brand name. The company also operates Re.Ra.Ku College that offers continuing training for franchise owners, home office staff, and salon staff covering topics, such as customer service, salon operations, and relaxation techniques. The company was formerly known as MEDIROM Inc. and changed its name to MEDIROM Healthcare Technologies Inc. in March 2020. MEDIROM Healthcare Technologies Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.…
MEDIROM Announces Receipt of Nasdaq Delisting Notice, Filing of Annual Report and Submission of Hearing Request
MEDIROM Healthcare Technologies (NASDAQ: MRM) is listed on Nasdaq, where its shares trade in USD. It belongs to the Personal Services industry, part of the Consumer Cyclical sector, and reports about 334 employees.
The shares were at 0.2300 USD on 20 November 2026, down 89.0% over 52 weeks. Its 52-week range is 0.2209 USD to 2.330 USD: the price is 90.1% below the high and 4.1% above the low.
Its market capitalisation is 1.82M USD.
MEDIROM Healthcare Technologies reports return on equity of 15.9%, an operating margin of -2.4% and revenue down 6.7% year over year.
Its debt exceeds its cash by 3.89B JPY, a debt-to-equity ratio of 4.24. Its Piotroski F-score is 6 out of 9, an average reading of its financial health.
No upcoming events tracked.